Nader Francois
Insider CIK 1365343 · XLRN Director · TRVN Director · BXLT Director · TECX Director · MRNA Director · PRVL Director · TALS Director · NPSP President, CEO and Director, Director · ALXN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRNA Moderna, Inc. | A Award deriv | 2026-05-06 | 2026-05-08 | 4,185 | — | $0 | 4,185 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2026-05-06 | 2026-05-08 | 6,454 | — | $0 | 6,454 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2026-04-30 | 2026-05-04 | 12,174 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2026-04-30 | 2026-05-04 | 12,174 | — | $0 | 32,781 | SEC↗ |
| TECX Tectonic Therapeutic, Inc. | A Award deriv | 2026-04-01 | 2026-04-03 | 20,400 | — | $0 | 20,400 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2025-04-30 | 2025-05-01 | 12,174 | — | $0 | 12,174 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2025-04-30 | 2025-05-01 | 6,378 | — | $0 | 6,378 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2024-05-06 | 2024-05-07 | 7,557 | — | $0 | 7,557 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 41,000 | — | $0 | 41,000 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 6,134 | — | $0 | 6,134 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-25 | 2022-07-25 | 138,500 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-25 | 2022-07-25 | 138,500 | — | $0 | 386,932 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-25 | 2022-09-13 | 138,500 | — | $0 | 386,932 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-25 | 2022-09-13 | 138,500 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-21 | 2022-07-25 | 248,432 | — | $0 | 87,735 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-21 | 2022-07-25 | 248,432 | — | $0 | 248,432 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-21 | 2022-07-25 | 36,500 | $3.72 | $135.8K | 138,500 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-21 | 2022-09-13 | 36,500 | $3.72 | $135.8K | 138,500 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-21 | 2022-09-13 | 248,432 | — | $0 | 248,432 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | J Other | 2022-07-21 | 2022-09-13 | 248,432 | — | $0 | 147,255 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-20 | 2022-07-25 | 52,000 | $3.62 | $188.2K | 102,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-20 | 2022-09-13 | 52,000 | $3.62 | $188.2K | 102,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-19 | 2022-07-25 | 50,000 | $3.52 | $176.0K | 50,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2022-07-19 | 2022-09-13 | 50,000 | $3.52 | $176.0K | 50,000 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 14,501 | — | $0 | 14,501 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2022-05-10 | 2022-05-12 | 23,100 | — | $0 | 16,620 | SEC↗ |
| MRNA Moderna, Inc. | S Sale | 2022-05-10 | 2022-05-12 | 3,196 | $136.10 | $435.0K | 20,607 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2022-05-10 | 2022-05-12 | 23,100 | $18.87 | $435.9K | 23,803 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2022-04-28 | 2022-05-02 | 5,415 | — | $0 | 5,415 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise deriv | 2022-04-28 | 2022-05-02 | 703 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | M Exercise | 2022-04-28 | 2022-05-02 | 703 | — | $0 | 703 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | G Gift | 2021-12-15 | 2021-12-16 | 59,520 | — | $0 | 336,167 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 3,222 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 8,185 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 20,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 576 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 7,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 6,749 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer | 2021-07-21 | 2021-07-23 | 13,921 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 673 | — | $0 | 13,921 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 1,962 | — | $0 | 13,248 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2021-04-28 | 2021-04-30 | 703 | — | $0 | 703 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2021-04-28 | 2021-04-30 | 4,081 | — | $0 | 4,081 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 3,222 | — | $0 | 3,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 1,622 | — | $0 | 6,749 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 32,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 17,000 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | D To issuer deriv | 2021-01-22 | 2021-01-26 | 133,447 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | U Tender | 2021-01-22 | 2021-01-26 | 23,747 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-05-14 | 2020-05-18 | 3,468 | — | $0 | 10,345 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-05-14 | 2020-05-18 | 941 | — | $0 | 11,286 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2020-04-29 | 2020-04-30 | 18,270 | — | $0 | 18,270 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 8,185 | — | $0 | 8,185 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 1,377 | — | $0 | 5,127 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2019-12-10 | 2019-12-11 | 39,720 | $18.87 | $749.5K | 39,720 | SEC↗ |
| MRNA Moderna, Inc. | A Award deriv | 2019-12-10 | 2019-12-11 | 17,889 | $18.87 | $337.6K | 17,889 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 23,747 | — | $0 | 0 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 23,747 | — | $0 | 23,747 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-05-15 | 2019-05-17 | 2,726 | — | $0 | 6,877 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 3,750 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-05-09 | 2018-05-11 | 2,174 | — | $0 | 4,151 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 1,250 | — | $0 | 2,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-11-29 | 2017-11-30 | 1,977 | — | $0 | 1,977 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 1,250 | — | $0 | 1,250 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 5,960 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer | 2016-06-03 | 2016-06-07 | 7,657 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-05-10 | 2016-05-12 | 4,500 | — | $0 | 7,657 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BXLT Baxalta Inc | A Award deriv | 2015-07-27 | 2015-07-29 | 5,960 | — | $0 | 5,960 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2015-07-27 | 2015-07-29 | 3,140 | — | $0 | 3,140 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2015-05-20 | 2015-05-21 | 8,870 | — | $0 | 8,870 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-04-06 | 2015-04-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 19,598 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 80,912 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 109,602 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 82,826 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 67,636 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 154,284 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 133,125 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 104,438 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 196,018 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 106,643 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 24,302 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 115,432 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 27,926 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | U Tender | 2015-02-21 | 2015-02-24 | 276,955 | $46.00 | $12.74M | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-13 | 2015-02-20 | 24,301 | — | $0 | 24,302 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-13 | 2015-02-20 | 12,600 | $45.88 | $578.1K | 276,955 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-13 | 2015-02-20 | 24,301 | — | $0 | 289,555 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 3,262 | — | $0 | 104,438 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 24,466 | — | $0 | 191,534 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 5,625 | — | $0 | 67,636 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 9,798 | — | $0 | 19,598 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 80,912 | — | $0 | 80,912 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2015-02-12 | 2015-02-20 | 653 | — | $0 | 106,643 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 9,798 | — | $0 | 270,197 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 653 | $38.27 | $25.0K | 260,399 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 3,262 | $8.21 | $26.8K | 259,746 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 24,466 | $3.34 | $81.7K | 256,484 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-12 | 2015-02-20 | 4,943 | $45.85 | $226.6K | 265,254 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2015-02-12 | 2015-02-20 | 5,625 | $3.25 | $18.3K | 232,018 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2015-02-07 | 2015-02-20 | 7,263 | $45.85 | $333.0K | 226,393 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2015-02-07 | 2015-02-20 | 20,301 | — | $0 | 233,656 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-04-08 | 576 | — | $0 | 576 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 576 | — | $0 | 576 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2014-12-11 | 2014-12-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-05-14 | 2014-05-15 | 8,870 | — | $0 | 8,870 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2014-02-13 | 2014-02-14 | 24,301 | — | $0 | 48,603 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2014-02-13 | 2014-02-14 | 24,301 | — | $0 | 245,423 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-13 | 2014-02-14 | 11,767 | $38.30 | $450.7K | 233,656 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-04-18 | 40,500 | — | $0 | 40,500 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 107,296 | — | $0 | 107,296 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 29,396 | — | $0 | 29,396 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2014-02-07 | 2014-02-11 | 20,300 | — | $0 | 228,380 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2014-02-07 | 2014-02-11 | 7,258 | $35.13 | $255.0K | 221,122 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-01-30 | 2014-01-31 | 17,741 | — | $0 | 17,741 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-01-07 | 2014-01-09 | 20,250 | — | $0 | 216,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 4,875 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 3,750 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 2,625 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 9,030 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 2,771 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 2,308 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 1,775 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 1,243 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 64,356 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 16,739 | — | $0 | 73,261 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 10,398 | — | $0 | 109,602 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 5,850 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 4,500 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 3,150 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 5,746 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 9,030 | $4.13 | $37.3K | 169,303 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 64,356 | $5.73 | $368.8K | 152,176 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 1,243 | $4.07 | $5.1K | 153,419 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 1,775 | $4.50 | $8.0K | 155,194 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 10,398 | $5.71 | $59.4K | 210,197 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 5,850 | $6.16 | $36.0K | 199,799 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 4,500 | $5.85 | $26.3K | 193,949 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 3,150 | $5.05 | $15.9K | 189,449 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 5,746 | $3.60 | $20.7K | 186,299 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 4,875 | $3.93 | $19.2K | 180,553 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 3,750 | $4.10 | $15.4K | 175,678 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 2,625 | $4.42 | $11.6K | 171,928 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 16,739 | $3.25 | $54.4K | 226,936 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 2,771 | $4.31 | $11.9K | 160,273 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 2,308 | $4.37 | $10.1K | 157,502 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-27 | 2013-09-30 | 17,008 | — | $0 | 4,500 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-27 | 2013-09-30 | 16,650 | — | $0 | 5,850 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-27 | 2013-09-30 | 9,800 | — | $0 | 82,826 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-27 | 2013-09-30 | 9,800 | $5.71 | $56.0K | 131,278 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-27 | 2013-09-30 | 17,008 | $5.85 | $99.5K | 104,828 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-27 | 2013-09-30 | 16,650 | $6.16 | $102.6K | 121,478 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-27 | 2013-09-30 | 43,458 | $32.36 | $1.41M | 87,820 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-26 | 2013-09-30 | 992 | — | $0 | 21,508 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-09-26 | 2013-09-30 | 19,350 | — | $0 | 3,150 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-26 | 2013-09-30 | 992 | $5.85 | $5.8K | 237,820 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-26 | 2013-09-30 | 6,497 | $33.60 | $218.3K | 87,820 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-09-26 | 2013-09-30 | 143,503 | $33.07 | $4.75M | 94,317 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-09-26 | 2013-09-30 | 19,350 | $5.05 | $97.7K | 236,828 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-10 | 2013-04-10 | 54,000 | — | $0 | 54,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-10 | 2013-04-10 | 16,754 | — | $0 | 5,746 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-10 | 2013-04-10 | 58,231 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-04-10 | 2013-04-10 | 148,367 | $11.68 | $1.73M | 217,478 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-10 | 2013-04-10 | 54,000 | $3.34 | $180.4K | 365,845 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-10 | 2013-04-10 | 16,754 | $3.60 | $60.3K | 311,845 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-10 | 2013-04-10 | 58,231 | $3.85 | $224.2K | 295,091 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-09 | 2013-04-10 | 41,769 | — | $0 | 58,231 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-09 | 2013-04-10 | 13,875 | — | $0 | 4,875 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-09 | 2013-04-10 | 15,000 | — | $0 | 3,750 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-09 | 2013-04-10 | 79,356 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-04-09 | 2013-04-10 | 150,000 | $11.27 | $1.69M | 236,860 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-09 | 2013-04-10 | 41,769 | $3.85 | $160.8K | 386,860 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-09 | 2013-04-10 | 13,875 | $3.93 | $54.5K | 345,091 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-09 | 2013-04-10 | 15,000 | $4.10 | $61.5K | 331,216 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-09 | 2013-04-10 | 79,356 | $4.29 | $340.4K | 316,216 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 6,104 | — | $0 | 2,771 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 35,644 | — | $0 | 64,356 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 7,632 | — | $0 | 1,243 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 7,100 | — | $0 | 1,775 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 6,567 | — | $0 | 2,308 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 15,358 | — | $0 | 79,356 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 16,125 | — | $0 | 2,625 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-04-08 | 2013-04-10 | 55,470 | — | $0 | 9,030 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 55,470 | $4.13 | $229.1K | 355,377 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 35,644 | $5.73 | $204.2K | 272,504 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 7,632 | $4.07 | $31.1K | 280,136 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 7,100 | $4.50 | $31.9K | 287,236 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 6,567 | $4.37 | $28.7K | 293,803 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 6,104 | $4.31 | $26.3K | 299,907 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | S Sale | 2013-04-08 | 2013-04-10 | 150,000 | $11.01 | $1.65M | 236,860 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 15,358 | $4.29 | $65.9K | 386,860 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-04-08 | 2013-04-10 | 16,125 | $4.42 | $71.3K | 371,502 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise deriv | 2013-02-19 | 2013-02-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-19 | 2013-02-21 | 21,624 | $8.01 | $173.2K | 236,126 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | M Exercise | 2013-02-19 | 2013-02-21 | 50,000 | — | $0 | 257,750 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 196,018 | — | $0 | 196,018 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2013-02-13 | 2013-02-15 | 72,904 | — | $0 | 72,904 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2013-02-07 | 2013-02-11 | 7,193 | $8.61 | $61.9K | 207,750 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2013-02-07 | 2013-02-11 | 20,299 | — | $0 | 214,943 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | J Other | 2012-12-21 | 2013-01-07 | 30,450 | — | $0 | 165,111 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-12-21 | 2012-12-21 | 108,000 | — | $0 | 108,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | F Tax w/h | 2012-12-21 | 2012-12-26 | 11,068 | $9.10 | $100.7K | 154,043 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-02-07 | 2012-02-09 | 107,700 | — | $0 | 107,700 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 60,900 | — | $0 | 60,900 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award | 2012-02-07 | 2012-02-09 | 60,900 | — | $0 | 60,900 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-30 | 2012-02-01 | 54,000 | — | $0 | 54,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2012-01-20 | 2012-02-01 | 46,313 | — | $0 | 46,313 | SEC↗ |